Cosmo Pharmaceuticals N.V. (FRA:C43)

Germany flag Germany · Delayed Price · Currency is EUR
60.50
-0.50 (-0.82%)
Last updated: Jun 25, 2025
-15.97%
Market Cap 971.79M
Revenue (ttm) 266.79M
Net Income (ttm) 133.24M
Shares Out n/a
EPS (ttm) 8.12
PE Ratio 7.29
Forward PE 19.10
Dividend 2.05 (3.39%)
Ex-Dividend Date Jun 4, 2025
Volume n/a
Average Volume 21
Open 60.50
Previous Close 61.00
Day's Range 60.50 - 60.50
52-Week Range 47.80 - 86.50
Beta n/a
RSI 51.89
Earnings Date Jul 23, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 322
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C43
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.